Patellofemoral Pain Syndrome

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Ferring Pharmaceuticals
Ferring PharmaceuticalsArgentina - Buenos Aires
1 program
Intra-Articular Hyaluronic Acid-EuflexxaN/A1 trial
Active Trials
NCT01811654Completed30Est. Mar 2017
Plus Therapeutics
1 program
PENSN/A1 trial
Active Trials
NCT02441712CompletedEst. Dec 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Plus TherapeuticsPENS
Ferring PharmaceuticalsIntra-Articular Hyaluronic Acid-Euflexxa

Clinical Trials (2)

Total enrollment: 30 patients across 2 trials

Rehabilitation With Patterned Electrical Neuromuscular Stimulation for Patients With Patellofemoral Pain

Start: Mar 2015Est. completion: Dec 2017
N/ACompleted
NCT01811654Ferring PharmaceuticalsIntra-Articular Hyaluronic Acid-Euflexxa

Effectiveness Trial for Evaluating IAHA for PFPS

Start: Apr 2013Est. completion: Mar 201730 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space